Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Autoimmune Disease

CymaBay Announces Positive Top-Line Data from Phase 3 Trial of Seladelpar for Primary Biliary Cholangitis

CymaBay Therapeutics reported positive top-line results from the ENHANCE, a placebo-controlled, randomized, Phase 3 study evaluating the safety and efficacy […]

CymaBay Announces Positive Top-Line Data from Phase 3 Trial of Seladelpar for Primary Biliary Cholangitis
7 months ago
Share

Immunic Reports Positive Phase 2 Data from EMPhASIS Trial of IMU-838 for Relapsing-Remitting Multiple Sclerosis

Immunic Therapeutics reported positive top-line data from the phase 2 EMPhASIS trial evaluating IMU-838 versus placebo in patients with relapsing […]

Immunic Reports Positive Phase 2 Data from EMPhASIS Trial of IMU-838 for Relapsing-Remitting Multiple Sclerosis
7 months ago
Share

Indiana University School of Medicine & Eli Lilly and Co Ink 5-Year $5m Deal

Indiana University School of Medicine announced today a strategic research agreement with Eli Lilly and Company designed to, in the […]

Indiana University School of Medicine & Eli Lilly and Co Ink 5-Year $5m Deal
8 months ago
Share

World-Renowned Rheumatologist Researcher Brings New Scleroderma Program to Cedars-Sinai in Los Angeles

Francesco Boin, MD, a nationally recognized rheumatology expert, has been appointed the director  of the division of Rheumatology and director […]

World-Renowned Rheumatologist Researcher Brings New Scleroderma Program to Cedars-Sinai in Los Angeles
9 months ago
Share

New Study Trials Use of CT-P13 to Accelerate COVID-19 Recovery

Celltrion Healthcare is partnering with the University of Oxford and University Hospitals Birmingham to study the use of CT-P13 (biosimilar […]

New Study Trials Use of CT-P13 to Accelerate COVID-19 Recovery
9 months ago
Share

Georgia State University Biomedical Researcher Secures $1.95m to Study Cause of Autoimmunity

A Georgia State University professor received a five-year, $1.95 million federal grant to study the causes of autoimmunity in the […]

Georgia State University Biomedical Researcher Secures $1.95m to Study Cause of Autoimmunity
9 months ago
Share

Ocugen Discontinuing Phase 3 trial of OCU300 for Ocular Graft vs. Host Disease Following Interim Analysis

Ocugen announced the decision to discontinue the Phase 3 trial of OCU300 for ocular Graft vs. Host Disease (oGVHD). The decision […]

Ocugen Discontinuing Phase 3 trial of OCU300 for Ocular Graft vs. Host Disease Following Interim Analysis
9 months ago
Share

Results from SOBI’S Pivotal Phase 2/3 Study of Emapalumab in Patients with Primary HLH Published in New England Journal of Medicine

SOBI announced that the results from the pivotal phase 2/3 study evaluating the efficacy and safety of emapalumab in patients […]

Results from SOBI’S Pivotal Phase 23 Study of Emapalumab in Patients with Primary HLH Published in New England Journal of Medicine
10 months ago
Share

Akari Therapeutics Announces Positive Topline Results from Phase II Study of Nomacopan in Bullous Pemphigoid Patients

Akari Therapeutics announced that it achieved the primary and secondary endpoints in a phase 2 study evaluating nomacopan for the […]

Akari Therapeutics Announces Positive Topline Results from Phase II Study of Nomacopan in Bullous Pemphigoid Patients
10 months ago
Share

HSS-led Study Identifies Molecule in Lymphatic System Influences Autoimmune Diseases

The Hospital for Special Surgery (HSS) in New York City has discovered a molecule in the lymphatic system that could […]

HSS-led Study Identifies Molecule in Lymphatic System Influences Autoimmune Diseases
12 months ago
Share

Posts navigation

Older posts
Newer posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.